Accompanying Scientific Program for the Quality Contract Prevention of Postoperative Delirium in the Care of Older Patients (WB-QC-POD)
1 other identifier
observational
100
1 country
1
Brief Summary
In the course of a scientific accompanying program, the project pursues the goal of gaining further insight into a possible connection between various influencing factors and the development of postoperative delirium. Against this background, in addition to the primary goal of exploring delirium rates, we aim to identify associations between other secondary end goals like the internal circadian time or the heart rate variability and the occurrence of postoperative delirium. For this purpose, patients of the QC-POD (NCT04355195) sample will be studied.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 14, 2023
CompletedFirst Posted
Study publicly available on registry
May 6, 2023
CompletedStudy Start
First participant enrolled
June 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedJanuary 23, 2025
January 1, 2025
2 years
April 14, 2023
January 22, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of postoperative Delirium
Incidence of postoperative delirium in all postoperative patients in normal ward, intensive care unit and recovery room with a validated delirium screening tool at two points in time.
Up to the fifth postoperative day
Secondary Outcomes (12)
Duration of Delirium
The participants are followed up until the end of hospital stay, an expected average of 7 days
Bodytime
Before surgery
Chronotype 1
Up to three months
Chronotype 2
Up to three months
Heart rate variability 1
The participants are followed up until the end of hospital stay, an expected average of 7 days.
- +7 more secondary outcomes
Other Outcomes (3)
Proteomics
At the morning of surgery
Metabolomics
At the morning of surgery
Bodytime
At the morning of surgery
Eligibility Criteria
Patients aged ≥70 years, male and female, who are receiving surgery
You may qualify if:
- Age ≥ 70 years
- Male and female patients
- Patients who have been included in QC-POD
- surgery (elective and not elective)
You may not qualify if:
- Moribund patients (palliative situation)
- Insufficient knowledge of the German language
- Cardiac arrhythmia (e.g. atrial fibrillation)
- Presence of a pacemaker
- Condition after heart transplantation
- Inflammation in the area of the frontal sinus
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Anaesthesiology and Intensive Care Medicine, Campus Virchow-Klinikum (CVK) and Campus Charite Mitte (CCM), Charite - Universitätsmedizin Berlin
Berlin, 13353, Germany
Biospecimen
Blood samples (monocytes and Cholinesterase activity)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Claudia Spies, MD, Prof.
Charite University, Berlin, Germany
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of the Department of Anesthesiolgy and Intensive Care Medicine CC07
Study Record Dates
First Submitted
April 14, 2023
First Posted
May 6, 2023
Study Start
June 22, 2023
Primary Completion
July 1, 2025
Study Completion
September 1, 2025
Last Updated
January 23, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share